Annual Report

XPeng reports an 80% monthly sales jump but a yearly decline, while launching a major strategic expansion into Mexico and Latin America.

A one-time gain gave the micro-cap a profitable quarter, but rising costs and reliance on a single large asset raise questions about its long-term stability.

Interlink Electronics reports a wider Q4 loss but makes key moves in autonomous vehicle and robotic surgery sensors, signaling a major strategic pivot.

The Texas fuel supplier is preparing a Nasdaq/NYSE move, banking on high energy prices from the Iran War to bolster its financials for the ambitious jump.

Tencent Music posts record profits and a huge dividend, but a shrinking user base and a new policy to hide key metrics leave investors wary.

As Argan prepares its Q4 results, investors are watching if its record backlog and dual energy strategy can sustain its powerful year-end performance.

UiPath reports its first-ever annual profit and a new $500M buyback, but its strategic pivot to agentic AI faces scrutiny over slowing growth.

Calgary-based Rubellite Energy posts a stellar 2025, with record output and lower costs, now pivoting to advanced oil recovery for long-term growth.

After a 39% stock crash, Lakeland Industries' former CFO is sued over allegedly misleading investors about the company's deteriorating financial health.

Advantage Energy posts record 2025 results, slashing debt while boosting output and pioneering a major carbon capture project. What's next for the firm?

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

Automotive SaaS firm MotorK posts a dramatic financial turnaround, achieving positive cash flow in H2 2025 by leveraging AI and a bold customer strategy.

With its lead drug for a rare blood cancer nearing European submission, Cellectar Biosciences advances its targeted radiotherapy platform on two fronts.

Despite a full-year GAAP loss, AFC declares a dividend and shifts its strategy post-BDC conversion. Can it resolve legacy loans and find new growth?

Swiss sportswear giant On reports a landmark 2025 with record sales and ambitious goals, yet a currency hit complicates the bottom-line profit story.

Colombia's energy giant is set to reveal its 2025 performance, testing its diversification strategy against falling oil prices and high investor expectations.

The luxury marketplace achieved its first profitable quarter, a win for financial discipline. But with user metrics down, the focus now shifts to its 2026 growth plan.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

Legal tech firm DISCO reports strong growth fueled by a 600% surge in AI revenue, launching agentic AI and a disruptive new all-in-one pricing model.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.